Pimavanserin: a new treatment for the Parkinson's disease psychosis

• Published in: Tijdschrift voor psychiatrie Vol. 59; no. 9; p. 528
• Main Authors: Duits, J H, Ongering, M S, Martens, H J M, Schulte, P F J
• Format: Journal Article
• Language: Dutch
• Published: Netherlands 2017
• Subjects: Antipsychotic Agents - therapeutic use; Clozapine - adverse effects; Clozapine - therapeutic use; Humans; Parkinson Disease - complications; Piperidines - therapeutic use; Psychotic Disorders - drug therapy; Psychotic Disorders - etiology; Treatment Outcome; Urea - analogs & derivatives; Urea - therapeutic use

Clozapine is an effective drug for treating psychosis in Parkinson's disease (PDP) and is registered as such in the Netherlands. However, clozapine can have adverse effects, including agranulocytosis. The new drug pimavanserin was recently registered in the United States for the treatment of PD...